Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf M Mesters

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Cancer Research|March 15, 2008
Adjuvant therapy with small hairpin RNA interference prevents non-small cell lung cancer metastasis development in miceEtmar Bulk, Antje Hascher, Ruediger Liersch, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|June 27, 2015
Low-Energy Ultrasound Treatment Improves Regional Tumor Vessel Infarction by Retargeted Tissue FactorCaroline Brand, Stefanie Dencks, Georg Schmitz, et al.
Plos One|February 22, 2020
Radiation synergizes with antitumor activity of CD13-targeted tissue factor in a HT1080 xenograft model of human soft tissue sarcomaCaroline Brand, Burkhard Greve, Tobias Bölling, et al.
Cancers|July 2, 2021
Targeting Tissue Factor to Tumor Vasculature to Induce Tumor InfarctionAndrew F Berdel, Christian Schwöppe, Caroline Brand, et al.
Angiogenesis|October 19, 2013
Non-invasive monitoring of tumor-vessel infarction by retargeted truncated tissue factor tTF-NGR using multi-modal imagingThorsten Persigehl, Janine Ring, Christoph Bremer, et al.
Oncotarget|January 7, 2016
NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factorCaroline Brand, Christoph Schliemann, Janine Ring, et al.
Annals of Hematology|May 24, 2020
Long-term survival and polyclonal immunoglobulin reconstitution after allogeneic stem cell transplantation in multiple myelomaChristine Eisfeld, Eva Eßeling, Ramona Wullenkord, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
Bortezomib, dexamethasone, and fibroblast growth factor receptor 3-specific tyrosine kinase inhibitor in t(4;14) myelomaGuido Bisping, Doris Wenning, Martin Kropff, et al.
Journal of Medicinal Chemistry|March 19, 2013
Anticancer therapy by tumor vessel infarction with polyethylene glycol conjugated retargeted tissue factorChristian Schwöppe, Caroline Zerbst, Max Fröhlich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
S100A2 induces metastasis in non-small cell lung cancerEtmar Bulk, Bülent Sargin, Utz Krug, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Cancer Research|March 15, 2008
Adjuvant therapy with small hairpin RNA interference prevents non-small cell lung cancer metastasis development in miceEtmar Bulk, Antje Hascher, Ruediger Liersch, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|June 27, 2015
Low-Energy Ultrasound Treatment Improves Regional Tumor Vessel Infarction by Retargeted Tissue FactorCaroline Brand, Stefanie Dencks, Georg Schmitz, et al.
Plos One|February 22, 2020
Radiation synergizes with antitumor activity of CD13-targeted tissue factor in a HT1080 xenograft model of human soft tissue sarcomaCaroline Brand, Burkhard Greve, Tobias Bölling, et al.
Cancers|July 2, 2021
Targeting Tissue Factor to Tumor Vasculature to Induce Tumor InfarctionAndrew F Berdel, Christian Schwöppe, Caroline Brand, et al.
Angiogenesis|October 19, 2013
Non-invasive monitoring of tumor-vessel infarction by retargeted truncated tissue factor tTF-NGR using multi-modal imagingThorsten Persigehl, Janine Ring, Christoph Bremer, et al.
Oncotarget|January 7, 2016
NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factorCaroline Brand, Christoph Schliemann, Janine Ring, et al.
Annals of Hematology|May 24, 2020
Long-term survival and polyclonal immunoglobulin reconstitution after allogeneic stem cell transplantation in multiple myelomaChristine Eisfeld, Eva Eßeling, Ramona Wullenkord, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
Bortezomib, dexamethasone, and fibroblast growth factor receptor 3-specific tyrosine kinase inhibitor in t(4;14) myelomaGuido Bisping, Doris Wenning, Martin Kropff, et al.
Journal of Medicinal Chemistry|March 19, 2013
Anticancer therapy by tumor vessel infarction with polyethylene glycol conjugated retargeted tissue factorChristian Schwöppe, Caroline Zerbst, Max Fröhlich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
S100A2 induces metastasis in non-small cell lung cancerEtmar Bulk, Bülent Sargin, Utz Krug, et al.
Pageof 7